Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:anorectic
gptkb:chemical_compound |
| gptkbp:ATCCode |
A08AA06
|
| gptkbp:CASNumber |
634-03-7
|
| gptkbp:category |
gptkb:stimulant
gptkb:morpholine_derivative appetite suppressant |
| gptkbp:chemicalFormula |
C12H17NO
|
| gptkbp:eliminationHalfLife |
19-24 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:IUPACName |
3,4-dimethyl-2-phenylmorpholine
|
| gptkbp:legalStatus |
gptkb:Schedule_III_(US)
|
| gptkbp:mechanismOfAction |
gptkb:sympathomimetic_amine
|
| gptkbp:metabolism |
phenmetrazine
|
| gptkbp:molecularWeight |
191.27 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
gptkb:unknown
|
| gptkbp:PubChem_CID |
4757
DB00976 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
increased heart rate
insomnia elevated blood pressure dry mouth |
| gptkbp:synonym |
Adipost
Bontril Melfiat Plegine |
| gptkbp:UNII |
7CVX6T2UQ7
|
| gptkbp:usedFor |
obesity treatment
|
| gptkbp:bfsParent |
gptkb:Schedule_III_controlled_substances
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
phendimetrazine
|